Stock Price Forecast

March 18, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading XOMA Corp chart...

About the Company

xoma has an extensive portfolio of products, programs, and technologies that are the subject of licenses the company has in place with other biotech and pharmaceutical companies. many of these licenses are the result of the company's pioneering efforts in the discovery and development of antibody therapeutics. there are more than 20 such programs that are fully funded by partners and could produce milestone payments and royalty payments in the future. in order to maximize its value in a licensing transaction, xoma continues to invest in x358, an allosteric monoclonal antibody that reduces insulin receptor activity, as the antibody could have a major impact on the treatment of hyperinsulinism. for more information, visit www.xoma.com.

Exchange

NASDAQ

Website

https://www.xoma.com/

$4M

Total Revenue

123

Employees

$290M

Market Capitalization

-8.58

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $XOMA News

XOMA Corp (XOMA) Reports Mixed Financial Results for Q4 and Full Year 2023

10d ago, source:

Revenue: XOMA recorded total revenues of $1.8 million for Q4 and $4.8 million for the full year of 2023. Net Loss: The ...

Xoma: Q4 Earnings Snapshot

10d ago, source:

EMERYVILLE, Calif. — EMERYVILLE, Calif. — Xoma Corp. (XOMA) on Friday reported a loss of $21.5 million in its fourth quarter. On a per-share basis, the Emeryville, California-based company said it had ...

XOMA Corporation (XOMA) Interactive Stock Chart - Yahoo Finance

20d ago, source: Yahoo Finance

EMERYVILLE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at the ...

XOMA Corp XOMA

6d ago, source: Morningstar

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

XOMAO XOMA Corporation 8.375% DP PFD B

3d ago, source: Seeking Alpha

**NM signifies a non meaningful value. A dash signifies the data is not available.

XOMA to Present at Upcoming Investor Conferences in March

19d ago, source: Nasdaq

XOMA’s presentations can also be accessed by visiting the investor relations section of the Company’s website at www.xoma.com. A replay of each presentation will be available and archived on ...

Xoma: Q4 Earnings Snapshot

11d ago, source: Houston Chronicle

EMERYVILLE, Calif. (AP) — EMERYVILLE, Calif. (AP) — Xoma Corp. (XOMA) on Friday reported a loss of $21.5 million in its fourth quarter. On a per-share basis, the Emeryville, California-based ...

XOMA Corp

27d ago, source: U.S. News & World Report

These Fidelity mutual funds are excellent candidates for a long-term, buy-and-hold investor thanks to a combination of high diversification and low fees.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...